Two insiders familiar with the investigation revealed that as early as next week, Bayer will receive a objection statement listing why the EU's antitrust regulators will stop its proposed acquisition of Monsanto for US $ 66 billion (117.73, 0.43, 0.37%).
Anonymous sources said a clear list of objections would help the company deal with regulators' concerns, and the company could solve the problem by offering a compromise solution, with one person familiar with the matter saying executives of Bayer and Monsanto were in the EU on Tuesday Meetings, and regular contact to solve the problem.
EU competition commissioner Margrethe Vestager said last week that regulators are "very cautious" in examining the competition after Bayer and Monsanto mergers and acquisitions to ensure that farmers still have options and 'afford the prices of seeds and pesticides.' Earlier this year, When DuPont and Dow Chemical mergers and acquisitions, the former had to export most of its global R & D business to ease the EU's concerns about its merger.
The US regulator, the deal has been approved by the US CFIUS.According to Sina US stocks, Bayer said on Friday that the U.S. Foreign Investment Commission (CFIUS) on the company's proposed acquisition of Monsanto no national security concerns, the two The home company will continue to work with regulators to close the deal by early 2018.